DAAAK PHARMA INT. AS - 12864378 | Print Summary Report
STORYBOOK OÜ Tähe 129b, Tartu, 50113 ESTONIA (+372)7446645 info@scorestorybook.ee ssb.ee
[mo_oauth_login]

DAAAK PHARMA INT. AS

Summary report

Date of report 11.07.2026

DAAAK PHARMA INT. AS

Registered
Registration code: 12864378
Founded in: 11.06.2015 (11 years)
EMTAK:

VAT:
EE101908124 (start 16.09.16)
start end
16.09.2016 -

Former names

  • MN Pharm AS

Business address:

DAAAK
Tallinn, Kesklinn, Hobujaama 4
+372 5690 2404

Add DAAAK PHARMA INT. AS data to your system

Add DAAAK PHARMA INT. AS data to your information system with one click or download a CSV file. The data is enriched with direct links to Storybook reports. See also the list of machine-readable data.

keywords

  • ravimite hulgimüük

DAAAK PHARMA INT. AS

Scores and ratings

Reputation score

?
What is Reputation score?

Credit Score

?
Trustworthy 0.01

Loader
What is Credit Score?

Open the reports you want to print

Employees and salaries

DAAAK PHARMA INT. AS

Number of employees and estimated average salaries
?

DAAAK PHARMA INT. AS

Employee taxes and performance analysis
?
QuarterLabor taxes
paid		Number of employees
Turnover
Per Employee		Profit
per employee
2026 I........................
2025 IV........................
2025 III........................
2025 II........................
2025 I........................
2024 IV........................
2024 III........................
2024 II........................
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................
2016 III........................
2016 II........................
2016 I........................
2015 IV........................
2015 III........................
2015 II........................

Deciders and beneficiaries

DAAAK PHARMA INT. AS

Former decision-makers
?
Valeri Trofimov
★★★★

......

Related companies scores

Credit Score: ...

Reputation score: ...

Date of birth: ......

Active relations 4

Wholesale of motor vehicle parts and accessoriesBusiness adviceWholesale trade of various goods
Siarhei Kastsian
★★★★

......

Related companies scores

Credit Score: ...

Reputation score: ...

Date of birth: ......

Active relations 0

Yury Sazonau
★★★★

......

Related companies scores

Credit Score: ...

Reputation score: ...

Date of birth: ......

Active relations 0

DAAAK PHARMA INT. AS

History of right of representation
?
Field
Trading
Business age
11y
Beneficial country:
Estonia
 
Jelena Lerner ... - ...
Yury Sazonau ... - ...
Siarhei Kastsian ... - ...
Valeri Trofimov ... - ...
2015
2017
2018
2020
2021
2023
2024
2026
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

DAAAK PHARMA INT. AS

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
more_horiz
..................
100%

Former owners

NameCredit ScorePaymentBeginningEnding
!
..................
!
..................
check_indeterminate_small
..................
0.01
..................
!
..................
0.01
..................
check_indeterminate_small
..................
0.01
..................
0.01
..................

DAAAK PHARMA INT. AS

Other related parties
?

Former other persons

NameCredit ScorePartBeginning
check_indeterminate_small
............
more_horiz
............
check_indeterminate_small
............
more_horiz
............
!
............

Other related parties (invalid relations)

NameCredit ScorePartBeginningEnding
check_indeterminate_small
..................
check_indeterminate_small
..................
check_indeterminate_small
..................
check_indeterminate_small
..................
check_indeterminate_small
..................
more_horiz
..................
0.01
..................
0.01
..................
more_horiz
..................
more_horiz
..................
more_horiz
..................
more_horiz
..................
more_horiz
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

DAAAK PHARMA INT. AS

Goodwill

DAAAK PHARMA INT. AS

Taxes paid and estimated average salaries

DAAAK PHARMA INT. AS

Quarterly indicators
QuarterTurnoverTaxed turnoverLabour productivityLabour productivityEmployeesNational taxesLabor taxes
2026 I* ............* ..............................
2025 IV* ............* ..............................
2025 III* ............* ..............................
2025 II* ............* ..............................
2025 I* ............* ..............................
2024 IV* ............* ..............................
2024 III* ............* ..............................
2024 II* ............* ..............................
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................
2017 I* ............* ..............................
2016 IV* ............* ..............................
2016 III* ............* ..............................
2016 II* ............* ..............................
2016 I* ............* ..............................

DAAAK PHARMA INT. AS

Sales revenue by business area

DAAAK PHARMA INT. AS

Sales revenue by country

DAAAK PHARMA INT. AS

Financial indicators and prognosis

DAAAK PHARMA INT. AS

Financial raiting: "VERY GOOD" (2026 prognosis)
2026 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

DAAAK PHARMA INT. AS

Annual reports
Year Period Submitted Report PDF
2025 01.01.2025–31.12.2025 17.04.2026 ......
2024 01.01.2024–31.12.2024 30.06.2025 ......
2023 01.01.2023–31.12.2023 17.05.2024 ......
2022 01.01.2022–31.12.2022 27.04.2023 ......
2021 01.01.2021–31.12.2021 05.05.2022 ......
2020 01.01.2020–31.12.2020 14.06.2021 ......
2019 01.01.2019–31.12.2019 30.06.2020 ......
2018 01.01.2018–31.12.2018 25.06.2019 ......
2017 01.01.2017–31.12.2017 26.07.2018 ......
2016 01.01.2016–31.12.2016 14.06.2017 ......
2015 01.01.2015–31.12.2015 10.05.2016 ......

Liabilities and debts

DAAAK PHARMA INT. AS

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

DAAAK PHARMA INT. AS

Reports and assets-liabilities overview 11.07.2026
?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

DAAAK PHARMA INT. AS

Claims history
?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Creditors' claims ...... €

Total debt claims: ...... €

Latest events
...... ......

DAAAK PHARMA INT. AS

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2026 I* ...... €...... €...... €...... €......
2025 IV* ...... €...... €...... €...... €......
2025 III* ...... €...... €...... €...... €......
2025 II* ...... €...... €...... €...... €......
2025 I* ...... €...... €...... €...... €......
2024 IV* ...... €...... €...... €...... €......
2024 III* ...... €...... €...... €...... €......
2024 II* ...... €...... €...... €...... €......
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......
2017 I* ...... €...... €...... €...... €......
2016 IV* ...... €...... €...... €...... €......
2016 III* ...... €...... €...... €...... €......
2016 II* ...... €...... €...... €...... €......
2016 I* ...... €...... €...... €...... €......

DAAAK PHARMA INT. AS

Bailiff's enforcement proceedings as of 11.07.2026
?

Bailiff's enforcement proceedings MISSING

DAAAK PHARMA INT. AS

Regulations of the Payment Order Department as of 11.07.2026
?

Regulations of the Payment Order Department MISSING

DAAAK PHARMA INT. AS

Court orders in the register as of 11.07.2026
?
Logo

Puuduste kõrvaldamise määrus

02.05.2024

Regulation number: Ä 50009789 / M5

Regulation status has entered into force: 02.05.2024

Date of enforcement of order or additional period: 03.05.2024

Regulation status: Puudused kõrvaldatud

Logo

Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks

01.04.2024

Regulation number: Ä 50009789 / M4

Regulation status has entered into force: 08.04.2024

Date of enforcement of order or additional period: 01.04.2024

Regulation status: Puudused kõrvaldatud

Logo

Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks

18.04.2023

Regulation number: Ä 50009789 / M3

Regulation status has entered into force: 20.04.2023

Date of enforcement of order or additional period: 18.04.2023

Regulation status: Puudused kõrvaldatud

Logo

Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks

11.04.2023

Regulation number: Ä 50009789 / M2

Regulation status has entered into force: 11.04.2023

Date of enforcement of order or additional period: 11.04.2023

Regulation status: Jõustunud

Logo

Puuduste kõrvaldamise määrus

18.09.2020

Regulation number: Ä 50009789 / M1

Regulation status has entered into force: 04.10.2020

Date of enforcement of order or additional period: 18.09.2020

Regulation status: Puudused kõrvaldatud

DAAAK PHARMA INT. AS

Decisions of the Consumer Disputes Committee as of 11.07.2026
?

Consumer disputes MISSING

DAAAK PHARMA INT. AS

Court hearings as of 11.07.2026
?

Court hearings MISSING

DAAAK PHARMA INT. AS

Rulings as of 11.07.2026
?

Court settlemets MISSING

DAAAK PHARMA INT. AS

Notices and announcements as of 11.07.2026
?
Logo

Notice of merger

10.07.2025
Äriühingu ühinemise teade
Avaldamise algus: 10.07.2025
Avaldamise lõpp: tähtajatu
DAAAK Pharma Int. AS (registrikood 12864378) avaldab teadaande äriseadustiku (ÄS) § 399 lõike 1 alusel.

Ühing teatab ühinemisest. Ühinemisel osalesid DAAAK Pharma Int. AS (registrikood 12864378) ja Tealverti OÜ (kustutatud) (registrikood: 14272682), asukoht: Harju maakond, Tallinn, Kesklinna linnaosa, Hobujaama tn 4, 10151.

Äriühingute võlausaldajatel palume esitada oma nõuded tagatise saamiseks kuue kuu jooksul käesoleva teate avaldamisest (ÄS § 399 lg 1).

Ärinimed
DAAAK Pharma Int. AS, kehtetud ärinimed: MN Pharm AS.
DAAAK Pharma Int. AS
Kesklinna linnaosa, Tallinn, Harju maakond, Hobujaama tn 4
Telefon: +372 55581540
E-post: Office.estonia@daaak.ee
Teadaande avaldaja kontaktandmed:
Jelena Lerner
Teadaande number 2477949
Logo

Notice of concluding a merger agreement of a public limited company

29.04.2025
Aktsiaseltsi ühinemislepingu sõlmimise teade
Avaldamise algus: 29.04.2025
Avaldamise lõpp: tähtajatu
DAAAK Pharma Int. AS (registrikood 12864378) avaldab teadaande äriseadustiku (ÄS) § 419 lõike 4 alusel.

Aktsiaselts teatab ühinemislepingu sõlmimisest. Ühinemisleping on sõlmitud DAAAK Pharma Int. AS (registrikood 12864378) ja Tealverti OÜ (registrikood: 14272682), asukoht: Harju maakond, Tallinn, Kesklinna linnaosa, Hobujaama tn 4, 10151 vahel.

Ühinemislepingu ja teiste dokumentidega on võimalik tutvuda ja saada nende ärakirju Tartu Maakohtu registriosakonnas.

Ärinimed
DAAAK Pharma Int. AS, kehtetud ärinimed: MN Pharm AS.
DAAAK Pharma Int. AS
Kesklinna linnaosa, Tallinn, Harju maakond, Hobujaama tn 4
Telefon: +372 55581540
E-post: Office.estonia@daaak.ee
Teadaande number 2448099

Marketing

Business network

DAAAK PHARMA INT. AS

 Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

DAAAK PHARMA INT. AS

 Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events found.

Failed to load monitoring events.

We value your privacy

We use cookies to improve your browsing experience, provide personalized ads or content, and analyze our traffic. By clicking "allow all", you agree to our use of all cookies.